# Real World Study of Lapatinib Among Metastatic Breast Cancer Patients

> **NCT03894410** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 242 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03894410
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2019-11-15
- **Final completion:** 2020-05-20
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03894410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03894410, "Real World Study of Lapatinib Among Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT03894410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*